Sofiva Genomics Co.,Ltd. (TPEX:6615)

Market Cap	669.40M
Revenue (ttm)	406.32M
Net Income (ttm)	-7.27M
Shares Out	21.59M
EPS (ttm)	-0.34
PE Ratio	n/a
Forward PE	n/a
Dividend	0.30 (0.97%)
Ex-Dividend Date	Jun 27, 2025

Volume	1,044
Average Volume	6,877
Open	30.80
Previous Close	31.00
Day's Range	30.80 - 30.80
52-Week Range	29.00 - 53.90
Beta	0.11
RSI	46.88
Earnings Date	Aug 13, 2025

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screenin...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2012
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6615

Financial Performance

In 2024, Sofiva Genomics's revenue was 453.31 million, a decrease of -2.89% compared to the previous year's 466.80 million. Earnings were 18.43 million, an increase of 59.89%.